ANUPAM RASAYANAnupam Rasayan India Ltd.NSE:ANURASTechnicalAnalystSucritAnupam Rasayan India Ltd. (CMP ₹1252, NSE: ANURAS) is a leading specialty chemicals manufacturer, incorporated in 1984. It focuses on custom synthesis and manufacturing of specialty chemicals for industries such as life sciences, agrochemicals, pigments, and personal care. Promoter: Patel Family (Promoter Group) – 65.38% holding (Dec 2025) FY22–FY26 Snapshot Revenue Growth: CAGR ~18% over FY22–FY26, driven by strong demand in specialty chemicals. → Good Net Profit: FY26 PAT ~₹420 Cr, reflecting consistent growth. → Good Operating Margin: Maintained ~22–24%, showing strong efficiency. → Good Equity Capital: Stable, no major dilution. → Good Dividend Policy: Conservative, yield ~0.6% (FY26). → Neutral Asset Building: Expansion of manufacturing facilities in Gujarat. → Good Sales: FY26 revenue crossed ₹3,200 Cr, supported by exports and domestic demand. → Good Expense: Raw material costs remain high, impacting margins. → Neutral EPS: ~₹39.5 in FY26, reflecting steady profitability. → Good Institutional Interest & Ownership Trends Largest Promoter: Patel Family (Promoter Group) – 65.38% Largest FII: Nalanda India Fund Ltd. – 3.12% Largest DII: HDFC Mutual Fund – 2.85% Strategic Moves & Innovations Expansion into high‑margin specialty chemicals for global clients. Focus on long‑term contracts with agrochemical and pharma majors. Investment in green chemistry and sustainable processes. Strengthening export presence in Europe and North America. Cash Flow & Balance Sheet Strength Strong operating cash flows supported by long‑term contracts. Debt levels moderate, manageable with steady profits. Consistent profit growth supports scalability. Risk Factors Dependence on global chemical demand cycles. Margin sensitivity to raw material price fluctuations. Competition from other specialty chemical players (Aarti Industries, SRF, Navin Fluorine). Regulatory risks in chemical exports. Investor Takeaway Anupam Rasayan India Ltd. is a fast‑growing specialty chemicals company with strong promoter backing and rising institutional interest. With most snapshot parameters rated Good, the company shows consistent EPS growth, robust asset building, and strong sales momentum. Investors should monitor raw material costs and global demand cycles, but overall the outlook remains positive.